Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
breast-neoplasmslymphocytes
breast neoplasms, her2-negative, neoadjuvant chemotherapy, lymph node, lymphocytes, adoptive cell therapy, doxorubicin, epirubicin, cyclophosphamide, nab-paclitaxel, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 968555
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.